These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14360835)

  • 1. Carbohydrate metabolism in brain disease. V. Effect of epinephrine on intermediary carbohydrate metabolism in schizophrenic and manic-depressive psychoses.
    HENNEMAN DH; ALTSCHULE MD; GONCZ RM; DAVIS P
    AMA Arch Intern Med; 1955 Apr; 95(4):594-600. PubMed ID: 14360835
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbohydrate metabolism in brain disease. VII. The effect of glutathione on carbohydrate intermediary metabolism in schizophrenic and manic-depressive psychoses.
    ALTSCHULE MD; GONCZ RM; HENNEMAN DH; HOLLIDAY PD
    AMA Arch Intern Med; 1957 Jan; 99(1):22-7. PubMed ID: 13393830
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbohydrate metabolism in brain disease. II. Glucose metabolism in Schizophrenic, manic-depressive, and involutional psychoses.
    HENNEMAN DH; ALTSCHULE MD; GONCZ RM
    AMA Arch Intern Med; 1954 Sep; 94(3):402-16. PubMed ID: 13196721
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbohydrate metabolism in brain disease. VI. Lactate metabolism after infusion of sodium d-lactate in manic-depressive and schizophrenic psychoses.
    ALTSCHULE MD; HENNEMAN DH; HOLLIDAY P; GONCZ RM
    AMA Arch Intern Med; 1956 Jul; 98(1):35-8. PubMed ID: 13338892
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbohydrate metabolism in brain disease. IV. Effect of hydrocortisone and corticotropin (ACTH) on the metabolic effects of administered glucose in patients with chronic schizophrenic and manic-depressive psychoses.
    HENNEMAN DH; ALTSCHULE MD; GONCZ RM
    AMA Arch Intern Med; 1955 Feb; 95(2):241-6. PubMed ID: 13227650
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of the abnormal carbohydrate metabolism in schizophrenic and manic-depressive psychoses.
    ALTSCHULE MD
    Wis Med J; 1954 May; 53(5):308-10. PubMed ID: 13169894
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbohydrate metabolism in brain disease. III. Fructose metabolism in schizophrenic, manic-depressive, and involutional psychoses.
    HENNEMAN DH; ALTSCHULE MD; GONCZ RM
    AMA Arch Neurol Psychiatry; 1954 Dec; 72(6):696-704. PubMed ID: 13206488
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbohydrate metabolism in brain disease. XII. Effects of epinephrine on intermediary carbohydrate metabolism in normal and schizophrenic subjects.
    PERRIN GM; ALTSCHULE MD; HOLLIDAY PD; GONCZ RM
    AMA Arch Intern Med; 1959 May; 103(5):730-8. PubMed ID: 13636492
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbohydrate metabolism in brain disease. XIII. Effect of lactate infusion on blood keto-acid concentrations in schizophremic and manic-depressive psychoses.
    PERRIN GM; ALTSCHULE MD; HOLLIDAY PD
    Arch Intern Med; 1960 May; 105():752-4. PubMed ID: 14431985
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic differentiation of schizophrenic, manic-depressive and involutional psychoses.
    KALLMANN FJ
    AMA Arch Neurol Psychiatry; 1951 Feb; 65(2):246-7. PubMed ID: 14799000
    [No Abstract]   [Full Text] [Related]  

  • 11. [The relation between the month of birth and schizophrenic and manic-depressive psychoses].
    DE SAUVAGE NOLTING WJ
    Ned Tijdschr Geneeskd; 1951 Dec; 95(51):3855-64. PubMed ID: 14919727
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE CEREBRAL ATROPHIES].
    SABBATINI F
    Minerva Med; 1964 Sep; 55():2590-1. PubMed ID: 14199456
    [No Abstract]   [Full Text] [Related]  

  • 13. The oxidative activity of blood serum in schizophrenic and manic-depressive psychoses.
    WURTMAN RJ; FRANK MM; ALTSCHULE MD
    AMA Arch Intern Med; 1958 Nov; 102(5):790-4. PubMed ID: 13582265
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic variations in manic-depressive psychosis.
    DAWSON J; HULLIN RP; CROCKET BM
    J Ment Sci; 1956 Jan; 102(426):168-77. PubMed ID: 13307197
    [No Abstract]   [Full Text] [Related]  

  • 15. SYMPATHOMIMETIC PROPERTIES OF ADRENALINE METHYL ETHER.
    PAGE JA; HOFFER A
    Dis Nerv Syst; 1964 Sep; 25():558-64. PubMed ID: 14215247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transition of manic-depressive into schizophrenic states].
    SAHLI HR
    Psychiatr Neurol (Basel); 1959; 138():99-125. PubMed ID: 14440791
    [No Abstract]   [Full Text] [Related]  

  • 17. [PSYCHOPHARMACOLOGICAL LONG-TERM TREATMENT OF CHRONIC SCHIZOPHRENIA].
    JOST F
    Med Welt; 1963 Dec; 49():2499-503. PubMed ID: 14101636
    [No Abstract]   [Full Text] [Related]  

  • 18. The manic-depressive problem in the light of the schizoid process.
    GUNTRIP H
    Int J Psychoanal; 1962; 43():98-112. PubMed ID: 13902981
    [No Abstract]   [Full Text] [Related]  

  • 19. The family background and early life experience of the manic-depressive patient; a comparison with the schizophrenic patient.
    GIBSON RW
    Psychiatry; 1958 Feb; 21(1):71-90. PubMed ID: 13518443
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic and other factors in schizophrenic, manic-depressive, and schizo-affective psychoses.
    Stabenau JR
    J Nerv Ment Dis; 1977 Mar; 164(3):149-67. PubMed ID: 320288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.